Sean M. Hays

Best Publications

• Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework

  Russell S. Thomas;Martin A. Philbert;Scott S. Auerbach;Barbara A. Wetmore

  278
  Citations

• Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective

  Unknown

  263
  Citations

• Human biomonitoring assessment values: Approaches and data requirements

  Juergen Angerer;Lesa L. Aylward;Sean M. Hays;Birger Heinzow

  204
  Citations

• Dioxin risks in perspective: past, present, and future

  Unknown

  196
  Citations

• Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort.

  Lesa L Aylward;Robert C Brunet;Gaétan Carrier;Sean M Hays

  191
  Citations

• Sources of Variability in Biomarker Concentrations

  Lesa L. Aylward;Sean M. Hays;Roel Smolders;Holger M. Koch

  186
  Citations

• Characterizing Uncertainty and Variability in Physiologically Based Pharmacokinetic Models: State of the Science and Needs for Research and Implementation

  Hugh A. Barton;Weihsueh A. Chiu;R. Woodrow Setzer;Melvin E. Andersen

  177
  Citations

• Evaluation of Biomonitoring Data from the CDC National Exposure Report in a Risk Assessment Context: Perspectives across Chemicals

  Unknown

  176
  Citations

• Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.

  Sean M. Hays;Lesa L. Aylward;Judy S. LaKind;Michael J. Bartels

  165
  Citations

• Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.

  Unknown

  147
  Citations

• Variation in Urinary Flow Rates According to Demographic Characteristics and Body Mass Index in NHANES: Potential Confounding of Associations between Health Outcomes and Urinary Biomarker Concentrations

  Sean M. Hays;Lesa L. Aylward;Benjamin C. Blount

  142
  Citations

• Temporal trends in human TCDD body burden: decreases over three decades and implications for exposure levels

  Unknown

  139
  Citations

• Inter- and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 2: personal care product ingredients.

  Holger M. Koch;Lesa L. Aylward;Sean M. Hays;Roel Smolders

  134
  Citations

• Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9)

  Unknown

  119
  Citations

• Relationships of Chemical Concentrations in Maternal and Cord Blood: A Review of Available Data

  Unknown

  110
  Citations

• Biomonitoring equivalents for inorganic arsenic.

  Unknown

  103
  Citations

• Biomonitoring Equivalents for selenium.

  Unknown

  101
  Citations

• Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context.

  Unknown

  100
  Citations

• Variation in urinary spot sample, 24 h samples, and longer-term average urinary concentrations of short-lived environmental chemicals: implications for exposure assessment and reverse dosimetry.

  Unknown

  100
  Citations

• Interpreting variability in population biomonitoring data: Role of elimination kinetics

  Lesa L Aylward;Chris R Kirman;John L Adgate;Lisa M McKenzie

  100
  Citations